Frontiers Editorial Office
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
An expression of concern on
Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal Haze
With this notice, Frontiers states its awareness of serious allegations surrounding the article “Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal Haze” published on 5 May 2017. Our Chief Editors will direct an investigation in full accordance with our procedures. The situation will be updated as soon as the investigation is complete.
UPDATE: This article has now been corrected. Please find the full correction here: https://doi.org/10.3389/fphar.2018.01434
Citation: Frontiers Editorial Office (2017) Expression of Concern: Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal Haze. Front. Pharmacol. 8:427. doi: 10.3389/fphar.2017.00427
Received: 14 June 2017; Accepted: 14 June 2017;
Published: 28 June 2017.
Edited and reviewed by: Théophile Godfraind, Université Catholique de Louvain, Belgium
Copyright © 2017 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, ZWRpdG9yaWFsLm9mZmljZUBmcm9udGllcnNpbi5vcmc=